Search: Articles

Eureka 93 Inc., Vitality CBD Natural Health Products Inc. and Mercal Capital Corp. Execute Definitive Amalgamation Agreement

Ottawa, Ontario, April 26, 2019 (GLOBE NEWSWIRE) — Eureka 93 Inc. (“Eureka93”) (CSE:ERKA) (formerly LiveWell Canada Inc.), Vitality CBD Natural Health Products Inc. (“Vitality”), and Mercal Capital Corp. (“Mercal”) (NEX:MUL.H) today announced that they have executed a definitive amalgamation agreement (the “Agreement”) to effect the proposed transaction as described in the joint management information circular of Eureka93, Vitality and Mercal…

For cannabis stock Tilray (TLRY), marijuana oversupply could be a good thing

The world needs weed — and for marijuana products manufacturer Tilray (TLRY), that’s both a problem and a source of potential profit. Last November — just a month after Canada officially legalized the sale of recreational pot —  MarketWatch made headlines with a report on how Canada is facing a “national shortage” of marijuana. Out of the 10 Canadian provinces, authorities in…

Valens GroWorks signs multi-year cannabis, hemp extraction pact with HEXO Corp

Valens GroWorks Corporation (CSE:VGW) announced Thursday that it has signed a multi-year extraction services agreement to provide cannabis and hemp extraction services to HEXO Corp.(TSX:HEXO) (NYSEAMERICAN:HEXO), a leading cannabis producer and consumer goods cannabis company. The agreement has an initial two-year term from the date of the first shipment, with HEXO supplying Valens with an annual minimum of 30,000 kilograms in…

Acreage Deal helps Canopy Growth more than it helps CGC stock

Canopy Growth (NYSE:CGC) has surged higher on a deal that will position the firm to buy U.S.-based Acreage Holdings (OTCMKTS:ACRGF). The agreement, contingent on the U.S. legalizing marijuana at the federal level, would position Canopy as the leading cannabis company in the U.S. Unfortunately for investors, Canopy Growth is not CGC stock. With CGC trading at bubble-like multiples and the challenges facing marijuana…

3 reasons Aphria Inc’s (TSX:APHA) stock has been tanking

It’s been almost six months since cannabis was legalized nationwide, and marijuana stocks are once again on the rise. One, however, is not rising with the tide. Over the past month, shares of Aphria Inc (TSX:APHA)(NYSE:APHA) have fallen 18.8%, with a particularly sharp sell-off having occurred in the past week. If you zoom out to a longer time horizon, the losses have…

Tilray hosts ribbon cutting for Portugal campus after harvest

As Canadian cannabis companies increasingly look to expand in burgeoning European markets, British Columbia-based Tilray(NASDAQ:TLRY) today held a ribbon cutting ceremony for the launch of a campus in the European Union (EU).   Located in Cantanhede, Portugal, the facility just completed a successful indoor harvest that was celebrated with a tour featuring local government officials and Canadian healthcare professionals.   The $20 million campus…

Could HEXO (HEXO) be the next marijuana acquisition target?

Money and marijuana: two green substances that investors seemingly can’t get enough of right now. Since the year began, the Horizons Marijuana Life Sciences ETF, which holds an assortment of roughly four dozen pot stocks of various weightings, has nearly tripled the performance of the broad-based S&P 500 (which is also having its best start to a year in decades). With global weed…

A top Wall Street analyst loves Aurora Cannabis, Canopy Growth, and HEXO — should you?

Once upon a time, Wall Street analysts wouldn’t touch a marijuana stock with a 10-foot pole. Now many of the same analysts are cuddling up to quite a few pot stocks. The latest example of Wall Street’s fascination comes from Bank of America. Last week, analyst Christopher Carey initiated coverage on three marijuana stocks with positive views: Aurora Cannabis(NYSE:ACB), Canopy Growth (NYSE:CGC), and HEXO (NYSEMKT:HEXO). Carey…

2 marijuana stocks with rapidly declining short interest

Marijuana stocks have had a particularly strong start to 2019, with the first-ever cannabis exchange-traded fund, the Horizons Marijuana Life Sciences ETF, nearly tripling up the return of the S&P 500 since Jan. 1. The legalization of recreational marijuana in Canada last year, coupled with ongoing legalizations throughout the U.S. and the world, have both Wall Street and investors seeing green. But as…

A top Wall Street analyst loves Aurora Cannabis, Canopy Growth, and HEXO — should you?

Once upon a time, Wall Street analysts wouldn’t touch a marijuana stock with a 10-foot pole. Now many of the same analysts are cuddling up to quite a few pot stocks. The latest example of Wall Street’s fascination comes from Bank of America. Last week, analyst Christopher Carey initiated coverage on three marijuana stocks with positive views: Aurora Cannabis(NYSE:ACB), Canopy Growth (NYSE:CGC), and HEXO (NYSEMKT:HEXO). Carey…